Shoulder Innovations (NYSE:SI) Major Shareholder Healthcare Holding B.V. Gilde Sells 1,196 Shares

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 1,196 shares of the company’s stock in a transaction that occurred on Wednesday, August 26th. The shares were sold at an average price of $22.60, for a total value of $27,029.60. Following the completion of the sale, the insider owned 2,185,914 shares in the company, valued at approximately $49,401,656.40. This represents a 0.05% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Monday, August 24th, Healthcare Holding B.V. Gilde sold 681 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.62, for a total transaction of $15,404.22.
• On Friday, August 21st, Healthcare Holding B.V. Gilde sold 20,516 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.61, for a total transaction of $463,866.76.
• On Thursday, August 20th, Healthcare Holding B.V. Gilde sold 3,900 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.60, for a total transaction of $88,140.00.
• On Thursday, August 6th, Healthcare Holding B.V. Gilde sold 2,095 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.60, for a total transaction of $47,347.00.
• On Wednesday, August 5th, Healthcare Holding B.V. Gilde sold 7,338 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.64, for a total transaction of $166,132.32.
• On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.77, for a total transaction of $2,272,719.24.
• On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.71, for a total value of $244,155.21.
• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.73, for a total value of $455,372.82.
• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The shares were sold at an average price of $23.36, for a total value of $659,803.20.

Shoulder Innovations Stock Down 0.9%

Shoulder Innovations stock opened at $21.07 on Friday. The firm has a market cap of $438.68 million and a price-to-earnings ratio of -10.97. Shoulder Innovations, Inc. has a 52 week low of $10.92 and a 52 week high of $24.59. The business’s 50-day moving average price is $21.29 and its 200 day moving average price is $16.82. The company has a quick ratio of 8.92, a current ratio of 10.71 and a debt-to-equity ratio of 0.12.

Shoulder Innovations (NYSE:SI) last announced its quarterly earnings results on Thursday, August 6th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.03). Shoulder Innovations had a negative net margin of 58.33% and a negative return on equity of 23.61%. The company had revenue of $17.18 million during the quarter. As a group, sell-side analysts anticipate that Shoulder Innovations, Inc. will post -1.9 earnings per share for the current year.

Analyst Upgrades and Downgrades

SI has been the topic of several analyst reports. UBS Group raised their price target on shares of Shoulder Innovations from $27.00 to $28.00 and gave the company a “buy” rating in a research report on Monday, August 10th. Weiss Ratings upgraded shares of Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday, August 3rd. Piper Sandler reissued an “overweight” rating and set a $25.00 target price (up from $19.00) on shares of Shoulder Innovations in a research note on Friday, August 7th. Finally, BTIG Research lifted their price target on Shoulder Innovations from $24.00 to $26.00 and gave the company a “buy” rating in a research note on Friday, August 7th. Five investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $25.50.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in Shoulder Innovations in the 3rd quarter worth $28,000. Compass Financial Management LLC purchased a new position in Shoulder Innovations during the second quarter valued at $30,000. Rhumbline Advisers purchased a new position in Shoulder Innovations during the third quarter valued at $54,000. California State Teachers Retirement System grew its position in shares of Shoulder Innovations by 412.4% in the second quarter. California State Teachers Retirement System now owns 2,941 shares of the company’s stock valued at $60,000 after purchasing an additional 2,367 shares during the period. Finally, Wells Fargo & Company MN grew its position in shares of Shoulder Innovations by 66.3% in the fourth quarter. Wells Fargo & Company MN now owns 5,250 shares of the company’s stock valued at $75,000 after purchasing an additional 2,094 shares during the period.

Shoulder Innovations Company Profile

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.